DocDollars

Oyster Point Pharma, Inc.

NJ · United States · Reporting entity ID 100001156899

Total reported 2019–2025
$20.9M
#309 of 2,960 reporting companies — 0% of all reported industry payments
$5.83M in general payments across 82,386 records, plus $15.1M in research funding across 1,290 records.

How it breaks down

General payments $5,833,682
Research funding $15,098,353

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Oyster Point Pharma, Inc. reported $20.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #309 of 2,960 reporting companies. 72% of that was research funding and 28% general payments such as consulting, speaking, food and travel. 82,386 general payment records and 1,290 research records were filed.

Common questions about Oyster Point Pharma, Inc.

How much has Oyster Point Pharma, Inc. paid US doctors?

Oyster Point Pharma, Inc. reported $20,932,035 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $5,833,682 in general payments, $15,098,353 in research funding.

How does Oyster Point Pharma, Inc. rank among drug and device companies?

It ranks #309 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Oyster Point Pharma, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.